Corticosteroid nasal irrigations vs sprays in chronic rhinosinusitis: a systematic review.
- 1Department of Otorhinolaryngology-Head and Neck Surgery, Hospital Kemaman, Terengganu, Malaysia.
Abstract
Chronic rhinosinusitis (CRS) is a chronic inflammatory condition often treated with topical corticosteroids. While nasal sprays are standard, corticosteroid nasal irrigations may improve drug delivery and outcomes. Enhanced drug delivery in CRS is important because it promotes effective deposition of medication into the paranasal sinuses, thereby strengthening anti-inflammatory effects. This systematic review and meta-analysis, conducted per PRISMA guidelines and registered in PROSPERO (CRD420251053183), evaluated randomised controlled trials comparing corticosteroid nasal irrigations to sprays in adults with CRS. Six randomised controlled trials (RCTs) involving 370 participants were included. Irrigations significantly improved health-related quality of life compared to sprays (standardized mean difference [SMD] -0.62; 95% confidence interval [CI] -1.09 to -0.15; p = 0.01), particularly in patients with nasal polyps and those without prior endoscopic sinus surgery. Significant reductions were also observed in nasal polyp scores (MD -0.58; p < 0.0001) and Lund-Mackay radiologic scores (MD -1.79; p = 0.01). No significant differences were found in nasal endoscopy scores or adverse events. In conclusion, corticosteroid nasal irrigations are a safe and effective alternative to sprays for CRS management, offering better symptom control and objective improvements. Further studies are needed to refine delivery protocols, assess the cost-effectiveness of corticosteroid nasal irrigations versus sprays, and evaluate their relative efficacy in both nonsurgical and postsurgical patients, as well as in those with or without nasal polyps.
Related
- Endotype and Sample Site-Related Periostin Upregulation in Chronic Rhinosinusitis with Nasal Polyposis: A Systematic Review
- Interleukin-17 in the Nasal Polyps of Patients with Chronic Rhinosinusitis Compared to Healthy Controls: A Systematic Review
- Artificial Intelligence in Chronic Rhinosinusitis: From Molecular Profiling to Personalized Clinical Management—A Systematic Review
- Eosinophil Granule Proteins in Chronic Rhinosinusitis: A Systematic Review of Biomarker Utility for Disease Characterization and Outcomes
- Increased expression of hPGDS‑PGD2 in patients with eosinophilic chronic rhinosinusitis with nasal polyps
BibTeX
@article{sim2026corticosteroid,
title = {{Corticosteroid nasal irrigations vs sprays in chronic rhinosinusitis: a systematic review.}},
author = {Linger Sim and Dayang Anis Asyikin Ahmad Nazari and Khairudin Abdullah},
journal = {Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale},
year = {2026},
month = oct,
doi = {10.14639/0392-100x-a1402},
url = {https://europepmc.org/article/MED/42969774},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Corticosteroid nasal irrigations vs sprays in chronic rhinosinusitis: a systematic review.
AU - Linger Sim
AU - Dayang Anis Asyikin Ahmad Nazari
AU - Khairudin Abdullah
PY - 2026
DA - 2026/10/01
JO - Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale
DO - 10.14639/0392-100x-a1402
UR - https://europepmc.org/article/MED/42969774
AB - Chronic rhinosinusitis (CRS) is a chronic inflammatory condition often treated with topical corticosteroids. While nasal sprays are standard, corticosteroid nasal irrigations may improve drug delivery and outcomes. Enhanced drug delivery in CRS is important because it promotes effective deposition of medication into the paranasal sinuses, thereby strengthening anti-inflammatory effects. This systematic review and meta-analysis, conducted per PRISMA guidelines and registered in PROSPERO (CRD420251053183), evaluated randomised controlled trials comparing corticosteroid nasal irrigations to sprays in adults with CRS. Six randomised controlled trials (RCTs) involving 370 participants were included. Irrigations significantly improved health-related quality of life compared to sprays (standardized mean difference [SMD] -0.62; 95% confidence interval [CI] -1.09 to -0.15; p = 0.01), particularly in patients with nasal polyps and those without prior endoscopic sinus surgery. Significant reductions were also observed in nasal polyp scores (MD -0.58; p < 0.0001) and Lund-Mackay radiologic scores (MD -1.79; p = 0.01). No significant differences were found in nasal endoscopy scores or adverse events. In conclusion, corticosteroid nasal irrigations are a safe and effective alternative to sprays for CRS management, offering better symptom control and objective improvements. Further studies are needed to refine delivery protocols, assess the cost-effectiveness of corticosteroid nasal irrigations versus sprays, and evaluate their relative efficacy in both nonsurgical and postsurgical patients, as well as in those with or without nasal polyps.
SN - 0392-100X
SN - 1827-675X
ER -